SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-311781
Filing Date
2020-12-07
Accepted
2020-12-07 16:28:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d93124d424b5.htm 424B5 482232
2 GRAPHIC g93124g10s57.jpg GRAPHIC 61094
  Complete submission text file 0001193125-20-311781.txt   567561
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223262 | Film No.: 201373030
SIC: 2836 Biological Products, (No Diagnostic Substances)